Responses
Scientific Abstracts
Late Breaking Abstracts
Late Breaking Abstract Session
LB0002 The astis trial: Autologous stem cell transplantation versus IV pulse cyclophosphamide in poor prognosis systemic sclerosis, first results
Compose a Response to This Article
Other responses
No responses have been published for this article.